Motus GI Holdings Inc
F:7M40
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (27.6), the stock would be worth €-13 854.1 (168 028% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0 | €8.25 |
0%
|
| Industry Average | 27.6 | €-13 854.1 |
-168 028%
|
| Country Average | 22.9 | €-11 482.83 |
-139 286%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Motus GI Holdings Inc
F:7M40
|
223.9k EUR | -0 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.7B USD | 56 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
163B USD | 25.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
122.9B USD | 36.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.1B USD | 22.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
86.7B USD | 23.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.8B USD | 43.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.8B EUR | 18.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.3B USD | 41.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.6B USD | 23.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.6B USD | 20.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.3 |
| Median | 22.9 |
| 70th Percentile | 33.2 |
| Max | 1 826 183.3 |
Other Multiples
Motus GI Holdings Inc
Glance View
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 30 full-time employees. The company went IPO on 2018-02-14. The firm is engaged in developing a medical device Pure-Vu System. Pure-Vu system consists of a workstation controller and a single-use, disposable sleeve that fits over standard and slim colonoscopes. The Pure-Vu System facilitates the cleaning of the colon during the colonoscopy procedure. Pure-Vu System integrates with standard and slim colonoscopes to enable safe and rapid cleansing during the procedure while preserving established procedural workflow and techniques by irrigating the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The firm is focused on GI bleeds clinical research . The firm's subsidiaries include Motus GI Medical Technologies, Ltd. and Motus GI, LLC.
